Douglas L. Looker

1.4k total citations
14 papers, 1.1k citations indexed

About

Douglas L. Looker is a scholar working on Epidemiology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Douglas L. Looker has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Douglas L. Looker's work include Trypanosoma species research and implications (7 papers), Research on Leishmaniasis Studies (7 papers) and Biochemical and Molecular Research (5 papers). Douglas L. Looker is often cited by papers focused on Trypanosoma species research and implications (7 papers), Research on Leishmaniasis Studies (7 papers) and Biochemical and Molecular Research (5 papers). Douglas L. Looker collaborates with scholars based in United States, Colombia and Kenya. Douglas L. Looker's co-authors include J. Joseph Marr, George S. Douvas, A. E. Vatter, Alfred J. Crowle, Randolph L. Berens, Gary L. Stetler, Stephen J. Hoffman, Steven L. Durfee, Antony J. Mathews and J. L. Tedesco and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Douglas L. Looker

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas L. Looker United States 13 435 421 378 293 201 14 1.1k
Danny L. Jue United States 22 332 0.8× 189 0.4× 344 0.9× 274 0.9× 113 0.6× 68 1.3k
Joseph J. Batenburg Netherlands 25 580 1.3× 232 0.6× 164 0.4× 94 0.3× 50 0.2× 52 1.8k
David A. Bobak United States 21 532 1.2× 203 0.5× 225 0.6× 366 1.2× 63 0.3× 38 1.4k
Paul E. Steele United States 20 379 0.9× 490 1.2× 48 0.1× 286 1.0× 51 0.3× 54 1.2k
André Kirn France 26 523 1.2× 611 1.5× 60 0.2× 755 2.6× 168 0.8× 57 2.0k
Franca Mannu Italy 22 346 0.8× 95 0.2× 82 0.2× 108 0.4× 325 1.6× 35 1.5k
Maria Isaguliants Russia 21 719 1.7× 670 1.6× 84 0.2× 292 1.0× 100 0.5× 90 1.9k
Giulia Fabozzi United States 15 240 0.6× 164 0.4× 102 0.3× 292 1.0× 50 0.2× 26 779
Gerald Bacher Switzerland 16 637 1.5× 278 0.7× 120 0.3× 319 1.1× 26 0.1× 24 1.5k
Cristina D. Rodrigues Portugal 10 381 0.9× 111 0.3× 88 0.2× 91 0.3× 359 1.8× 11 913

Countries citing papers authored by Douglas L. Looker

Since Specialization
Citations

This map shows the geographic impact of Douglas L. Looker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas L. Looker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas L. Looker more than expected).

Fields of papers citing papers by Douglas L. Looker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas L. Looker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas L. Looker. The network helps show where Douglas L. Looker may publish in the future.

Co-authorship network of co-authors of Douglas L. Looker

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas L. Looker. A scholar is included among the top collaborators of Douglas L. Looker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas L. Looker. Douglas L. Looker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kerwin, Bruce A., Michael J. Akers, Izydor Apostoł, et al.. (1999). Acute and Long-Term Stability Studies of Deoxy Hemoglobin and Characterization of Ascorbate-Induced Modifications. Journal of Pharmaceutical Sciences. 88(1). 79–88. 31 indexed citations
2.
Looker, Douglas L., et al.. (1994). [23] Expression of recombinant human hemoglobin in Escherichia coli. Methods in enzymology on CD-ROM/Methods in enzymology. 231. 364–374. 62 indexed citations
3.
Looker, Douglas L., Steven L. Durfee, Stephen J. Hoffman, et al.. (1992). A human recombinant haemoglobin designed for use as a blood substitute. Nature. 356(6366). 258–260. 224 indexed citations
4.
Williams, Diana L., Thomas P. Gillis, R J Booth, Douglas L. Looker, & James D. Watson. (1990). The Use of a Specific DNA Probe and Polymerase Chain Reaction for the Detection of Mycobacterium leprae. The Journal of Infectious Diseases. 162(1). 193–200. 89 indexed citations
5.
Hoffman, Stephen J., et al.. (1990). Expression of fully functional tetrameric human hemoglobin in Escherichia coli.. Proceedings of the National Academy of Sciences. 87(21). 8521–8525. 172 indexed citations
6.
Looker, Douglas L., et al.. (1988). A Tissue Culture System for the Growth of Several Species of Leishmania: Growth Kinetics and Drug Sensitivities. American Journal of Tropical Medicine and Hygiene. 38(2). 304–307. 12 indexed citations
7.
Looker, Douglas L., et al.. (1988). The Synergistic Action of Pyrazolopyrimidines and Pentavalent Antimony against Leishmania donovani and L. braziliensis. American Journal of Tropical Medicine and Hygiene. 39(3). 250–255. 22 indexed citations
8.
Looker, Douglas L., et al.. (1986). Growth of Leishmania donovani Amastigotes in the Continuous Human Macrophage Cell Line U937: Studies of Drug Efficacy and Metabolism. The Journal of Infectious Diseases. 154(2). 323–327. 31 indexed citations
9.
Looker, Douglas L., J. Joseph Marr, & Randolph L. Berens. (1986). Mechanisms of action of pyrazolopyrimidines in Leishmania donovani.. Journal of Biological Chemistry. 261(20). 9412–9415. 29 indexed citations
10.
Fish, Wallace R., J. Joseph Marr, Randolph L. Berens, et al.. (1985). Inosine analogs as chemotherapeutic agents for African trypanosomes: metabolism in trypanosomes and efficacy in tissue culture. Antimicrobial Agents and Chemotherapy. 27(1). 33–36. 35 indexed citations
11.
Douvas, George S., Douglas L. Looker, A. E. Vatter, & Alfred J. Crowle. (1985). Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infection and Immunity. 50(1). 1–8. 273 indexed citations
12.
Berens, Randolph L., J. Joseph Marr, Douglas L. Looker, Donald J. Nelson, & Stephen W. LaFon. (1984). Efficacy of Pyrazolopyrimidine Ribonucleosides Against Irypanosoma cruzi: Studies in Vitro and in Vivo with Sensitive and Resistant Strains. The Journal of Infectious Diseases. 150(4). 602–608. 15 indexed citations
13.
Looker, Douglas L., Randolph L. Berens, & J. Joseph Marr. (1983). Purine metabolism in Leishmania donovani amastigotes and promastigotes. Molecular and Biochemical Parasitology. 9(1). 15–28. 85 indexed citations
14.
Fish, Wallace R., Douglas L. Looker, J. Joseph Marr, & Randolph L. Berens. (1982). Purine metabolism in the bloodstream forms of trypanosoma gambiense and Trypanosoma rhodesiense. Biochimica et Biophysica Acta (BBA) - General Subjects. 719(2). 223–231. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026